Neurocrine Biosciences (NBIX)
NASDAQ:NBIX
Want to see NBIX full AI Analyst Report?
Neurocrine (NBIX) Ownership Overview
1.17% Insiders
26.84% Mutual Funds
21.81% Other Institutional Investors
29.13% ETFs
21.06% Public Companies and
Individual Investors
The ownership structure of Neurocrine (NBIX) stock is a mix of institutional, retail, and individual investors. Approximately 77.77% of the company’s stock is owned by Institutional Investors, 1.17% is owned by Insiders, and 21.06% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $719437014 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $19516095 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $263 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $65387832 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,544,754 | Institution | 11.48% | 1,782,048,227 | |
| 8,675,488 | Institution | 8.63% | 1,339,148,328 | |
| 7,742,780 | Institution | 7.70% | 1,195,175,521 | |
| 5,461,037 | Institution | 5.43% | 842,965,671 | |
| 4,428,563 | Institution | 4.40% | 683,592,985 | |
| 2,610,074 | Institution | 2.60% | 402,891,023 | |
| 1,244,229 | Institution | 1.24% | 192,059,188 | |
| 1,220,482 | Institution | 1.21% | 188,393,602 | |
| 1,179,084 | Institution | 1.17% | 182,003,406 | |
| 993,953 | Institution | 0.99% | 153,426,585 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,742,780 | Institution | 7.70% | 1,195,175,521 | |
| 4,428,563 | Institution | 4.40% | 683,592,985 | |
| 1,220,482 | Institution | 1.21% | 188,393,602 | |
| 1,179,084 | Institution | 1.17% | 182,003,406 | |
| 993,953 | Institution | 0.99% | 153,426,585 | |
| 925,683 | Institution | 0.92% | 142,888,428 | |
| 623,036 | Institution | 0.62% | 96,171,837 | |
| 597,566 | Institution | 0.59% | 92,240,288 | |
| 483,344 | Institution | 0.48% | 74,608,980 | |
| 473,847 | Institution | 0.47% | 73,143,023 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,395,723 | Institution | 3.38% | 529,053,643 | |
| 3,197,284 | Institution | 3.18% | 421,210,194 | |
| 3,000,296 | Institution | 2.98% | 285,478,164 | |
| 2,316,957 | Institution | 2.30% | 305,235,915 | |
| 1,297,294 | Institution | 1.29% | 170,905,512 | |
| 1,121,922 | Institution | 1.12% | 147,802,004 | |
| 755,771 | Institution | 0.75% | 116,660,812 | |
| 723,886 | Institution | 0.72% | 109,009,993 | |
| 718,985 | Institution | 0.72% | 112,017,863 | |
| 646,432 | Institution | 0.64% | 100,714,106 |
FAQ
Who Owns Neurocrine Biosciences (NBIX)?
According to the latest TipRanks data, approximately 21.81% of the company's stock is held by institutional investors, 1.17% is held by insiders, and 21.06% is held by retail investors.
What percentage of Neurocrine Biosciences (NBIX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 21.81% of Neurocrine Biosciences (NBIX) stock is held by institutional investors.
What percentage of Neurocrine Biosciences (NBIX) stock is held by retail investors?
According to the latest TipRanks data, approximately 21.06% of Neurocrine Biosciences (NBIX) stock is held by retail investors.
Who owns the most shares of Neurocrine Biosciences (NBIX)?
iShares owns the most shares of Neurocrine Biosciences (NBIX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.